Lincoln National Corp’s Medpace MEDP Stock Holding History

Lincoln National Corp’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,255	Closed	-$2.46M	–	1054
2023 Q2	$2.46M	Sell	10,255 -345	-3%	-$71.7K	0.05%	211
2023 Q1	$1.99M	Buy	10,600 +6,982	+193%	+$1.44M	0.04%	235
2022 Q4	$768K	Buy	+3,618	New	+$723K	0.02%	416
2018 Q4	–	Sell	-7,230	Closed	-$433K	–	505
2018 Q3	$433K	Buy	+7,230	New	+$395K	0.01%	294

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lincoln National Corp's MEDP Position: Q3 2023 in Review

Lincoln National Corp sold out of Medpace (MEDP) in Q3 2023, closing a stake of 10,255 shares — an estimated $2.46M sold.

Lincoln National Corp first reported a position in MEDP in Q3 2018 and held it in 4 quarters. The position peaked at $2.46M in Q2 2023. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

Lincoln National Corp reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
Lincoln National Corp sold 10,255 Medpace shares in Q3 2023, an estimated $2.46M.
Lincoln National Corp first reported a position in Medpace in Q3 2018 and held it in 4 quarters.
Lincoln National Corp's Medpace position peaked at $2.46M in Q2 2023.
488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Lincoln National Corp's 13F filing for Q3 2023, filed 6 Nov 2023.